CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.248
-0.001 (-0.36%)
At close: Nov 21, 2024, 4:00 PM
0.250
+0.002 (0.69%)
After-hours: Nov 21, 2024, 4:35 PM EST
CERO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -6.65 | -2.54 | -0.67 | -0.54 |
| Loss (Gain) From Sale of Investments | - | - | - | 0 |
| Other Operating Activities | -5.94 | -0.49 | -2.84 | -0.03 |
| Change in Accounts Payable | 0.8 | 1.88 | 1.64 | 0.02 |
| Change in Income Taxes | -0.54 | -0.58 | 0.6 | - |
| Change in Other Net Operating Assets | 1.02 | 0.2 | 0.17 | -0.65 |
| Operating Cash Flow | -9.13 | -1.52 | -1.09 | -1.2 |
| Other Investing Activities | -13.63 | -7.94 | 180.84 | -306 |
| Investing Cash Flow | -13.63 | -7.94 | 180.84 | -306 |
| Short-Term Debt Issued | - | 0.91 | 0.65 | - |
| Total Debt Issued | 0.49 | 0.91 | 0.65 | 0.09 |
| Total Debt Repaid | -0.32 | - | - | -0.09 |
| Net Debt Issued (Repaid) | 0.17 | 0.91 | 0.65 | - |
| Issuance of Common Stock | 4.17 | - | - | 315.21 |
| Repurchase of Common Stock | -27.84 | -33.48 | -139.35 | - |
| Other Financing Activities | 0.05 | - | - | -6.14 |
| Financing Cash Flow | -15.49 | -32.58 | -138.7 | 309.08 |
| Net Cash Flow | -38.25 | -42.04 | 41.04 | 1.88 |
| Free Cash Flow | -9.13 | -1.52 | -1.09 | -1.2 |
| Free Cash Flow Per Share | - | -0.23 | -0.05 | -0.12 |
| Levered Free Cash Flow | 5.92 | 5.11 | -13.44 | - |
| Unlevered Free Cash Flow | 5.92 | 5.11 | -13.44 | - |
| Change in Net Working Capital | -13 | -6.95 | 11.63 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.